Report Details

The acute repetitive seizures market is set for rapid growth over the forecast period. In terms of revenue, the global acute repetitive seizures market accounted for USD 210.0 Million in 2019 and is expected to reach USD 3,000.0 Million by 2026, growing at a CAGR of 46.7%.

Global Acute Repetitive Seizures Market: Overview

Acute repetitive seizures (ARS) is a condition characterized by a near temporal correlation of seizures that exceeds a patient's normal baseline seizure frequency. Acute repetitive seizures are a form of seizure that happens in people who have drug-resistant epilepsy. Cluster seizure, breakthrough seizure, seizure flurry, serial seizure, seizure cluster, or prolonged seizure are all terms used to describe this form of seizure. The acute repetitive seizure is described by the frequency of seizures in brief bursts, which can range from hours to minutes. The duration of these seizures varies depending on the diagnosis of epilepsy (mesial temporal lobe epilepsy, for example) and the patient's features. In women with mesial temporal lobe epilepsy, three catamenial seizures arise within two premenstrual days.

Global Acute Repetitive Seizures Market: Growth Factors

The global acute repetitive seizures market is driven by an increase in the number of clinical trials, a greater focus on the introduction of novel drugs, and a growth in demand for nasal sprays for the treatment of epilepsy. Emerging administration pathways for epileptic seizures, new prescription therapies, and hereditary causes linked to brain malformations and epileptic seizures are mostly a few of the main factors driving the global epileptic seizures treatment industry. Furthermore, the global market for epileptic seizure therapy is increasing due to an increase in the prevalence of coronary diseases, head trauma, alcohol misuse, brain tumors, and infections.

Global Acute Repetitive Seizures Market: Segmentation

The worldwide acute repetitive seizures market is bifurcated into its product, distribution channel, and regions. Based on product, the market is segregated into USL-261, Diastat Rectal Gel, AZ-002, NRL-1, Others. USL-261 is expected to grow at a lucrative CAGR within the forecast period. Because of its superior clinical profile and promising phase III performance, USL-21 has an advantage over the other products. Based on the distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online stores. Due to an improvement in the availability of prescriptions for severe disease disorders at these pharmacies, ease of entry, and an increase in the chain of retail pharmacies selling medications for acute repetitive seizures, the retail pharmacy segment is projected to grow at the highest CAGR. Geographically, the global acute repetitive seizures market is diversified into Asia-Pacific, North America, Latin America, Europe, and Middle East & Africa.

Global Acute Repetitive Seizures Market: Regional Analysis

North America region dominated the global acute repetitive seizures market in 2019 and is anticipated to continue its dominance in the upcoming years. The dominance of the North America market can be attributed to the rising awareness about epilepsy. The Asia Pacific region is anticipated to grow at the highest rate in the forecast period owing to the rising population in the region and increasing awareness of the population towards epilepsy treatment.

Global Acute Repetitive Seizures Market: Competitive Players

Some of the key players in the acute repetitive seizures market are UCB S.A., Neurelis, Inc., Alexza Pharmaceuticals, Valeant Pharmaceuticals North America LLC, Veriton Pharma, among others. 

Global Acute Repetitive Seizures Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Acute Repetitive Seizures
    • 1.2. Global Acute Repetitive Seizures Market, 2019 & 2026 (USD Million)
    • 1.3. Global Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 1.4. Global Acute Repetitive Seizures Market Absulute Revenue Opportunity, 2016 – 2026 (USD Million)
    • 1.5. Global Acute Repetitive Seizures Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  • Chapter 2 Acute Repetitive Seizures Market – Product Analysis
    • 2.1. Global Acute Repetitive Seizures Market – Product Overview
    • 2.2. Global Acute Repetitive Seizures Market Share, by Product, 2019 & 2026 (USD Million)
    • 2.3. USL-261
      • 2.3.1. Global USL-261 Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 2.4. NRL-1
      • 2.4.1. Global NRL-1 Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 2.5. AZ-002
      • 2.5.1. Global AZ-002 Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 2.6. Diastat Rectal Gel
      • 2.6.1. Global Diastat Rectal Gel Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 2.7. Others
      • 2.7.1. Global Others Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
  • Chapter 3 Acute Repetitive Seizures Market – Distribution Channel Analysis
    • 3.1. Global Acute Repetitive Seizures Market – Distribution Channel Overview
    • 3.2. Global Acute Repetitive Seizures Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
    • 3.3. Hospital Pharmacy
      • 3.3.1. Global Hospital Pharmacy Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 3.4. Retail Pharmacies
      • 3.4.1. Global Retail Pharmacies Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 3.5. Online Stores
      • 3.5.1. Global Online Stores Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
  • Chapter 4 Acute Repetitive Seizures Market – Regional Analysis
    • 4.1. Global Acute Repetitive Seizures Market Regional Overview
    • 4.2. Global Acute Repetitive Seizures Market Share, by Region, 2019 & 2026 (USD Million)
    • 4.3. North America
      • 4.3.1. North America Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
        • 4.3.1.1. North America Acute Repetitive Seizures Market, by Country, 2016 - 2026 (USD Million)
      • 4.3.2. North America Acute Repetitive Seizures Market, by Product, 2016 – 2026
        • 4.3.2.1. North America Acute Repetitive Seizures Market, by Product, 2016 – 2026 (USD Million)
      • 4.3.3. North America Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026
        • 4.3.3.1. North America Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026 (USD Million)
      • 4.3.4. U.S.
        • 4.3.4.1. U.S. Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.3.5. Canada
        • 4.3.5.1. Canada Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 4.4. Europe
      • 4.4.1. Europe Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
        • 4.4.1.1. Europe Acute Repetitive Seizures Market, by Country, 2016 - 2026 (USD Million)
      • 4.4.2. Europe Acute Repetitive Seizures Market, by Product, 2016 – 2026
        • 4.4.2.1. Europe Acute Repetitive Seizures Market, by Product, 2016 – 2026 (USD Million)
      • 4.4.3. Europe Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026
        • 4.4.3.1. Europe Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026 (USD Million)
      • 4.4.4. Germany
        • 4.4.4.1. Germany Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.4.5. France
        • 4.4.5.1. France Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.4.6. U.K.
        • 4.4.6.1. U.K. Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.4.7. Italy
        • 4.4.7.1. Italy Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.4.8. Spain
        • 4.4.8.1. Spain Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.4.9. Rest of Europe
        • 4.4.9.1. Rest of Europe Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 4.5. Asia Pacific
      • 4.5.1. Asia Pacific Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
        • 4.5.1.1. Asia Pacific Acute Repetitive Seizures Market, by Country, 2016 - 2026 (USD Million)
      • 4.5.2. Asia Pacific Acute Repetitive Seizures Market, by Product, 2016 – 2026
        • 4.5.2.1. Asia Pacific Acute Repetitive Seizures Market, by Product, 2016 – 2026 (USD Million)
      • 4.5.3. Asia Pacific Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026
        • 4.5.3.1. Asia Pacific Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026 (USD Million)
      • 4.5.4. China
        • 4.5.4.1. China Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.5.5. Japan
        • 4.5.5.1. Japan Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.5.6. India
        • 4.5.6.1. India Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.5.7. South Korea
        • 4.5.7.1. South Korea Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.5.8. South-East Asia
        • 4.5.8.1. South-East Asia Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.5.9. Rest of Asia Pacific
        • 4.5.9.1. Rest of Asia Pacific Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 4.6. Latin America
      • 4.6.1. Latin America Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
        • 4.6.1.1. Latin America Acute Repetitive Seizures Market, by Country, 2016 - 2026 (USD Million)
      • 4.6.2. Latin America Acute Repetitive Seizures Market, by Product, 2016 – 2026
        • 4.6.2.1. Latin America Acute Repetitive Seizures Market, by Product, 2016 – 2026 (USD Million)
      • 4.6.3. Latin America Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026
        • 4.6.3.1. Latin America Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026 (USD Million)
      • 4.6.4. Brazil
        • 4.6.4.1. Brazil Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.6.5. Mexico
        • 4.6.5.1. Mexico Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.6.6. Rest of Latin America
        • 4.6.6.1. Rest of Latin America Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
    • 4.7. The Middle-East and Africa
      • 4.7.1. The Middle-East and Africa Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
        • 4.7.1.1. The Middle-East and Africa Acute Repetitive Seizures Market, by Country, 2016 - 2026 (USD Million)
      • 4.7.2. The Middle-East and Africa Acute Repetitive Seizures Market, by Product, 2016 – 2026
        • 4.7.2.1. The Middle-East and Africa Acute Repetitive Seizures Market, by Product, 2016 – 2026 (USD Million)
      • 4.7.3. The Middle-East and Africa Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026
        • 4.7.3.1. The Middle-East and Africa Acute Repetitive Seizures Market, by Distribution Channel, 2016 – 2026 (USD Million)
      • 4.7.4. GCC Countries
        • 4.7.4.1. GCC Countries Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.7.5. South Africa
        • 4.7.5.1. South Africa Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
      • 4.7.6. Rest of Middle-East Africa
        • 4.7.6.1. Rest of Middle-East Africa Acute Repetitive Seizures Market, 2016 – 2026 (USD Million)
  • Chapter 5 Acute Repetitive Seizures Market – Competitive Landscape
    • 5.1. Competitor Market Share – Revenue
    • 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 5.3. Strategic Developments
      • 5.3.1. Acquisitions and Mergers
      • 5.3.2. New Products
      • 5.3.3. Research & Development Activities
  • Chapter 6 Company Profiles
    • 6.1. Neurelis, Inc.
      • 6.1.1. Company Overview
      • 6.1.2. Product/Service Portfulio
      • 6.1.3. Neurelis, Inc. Sales, Revenue, and Gross Margin
      • 6.1.4. Neurelis, Inc. Revenue and Growth Rate
      • 6.1.5. Neurelis, Inc. Market Share
      • 6.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.2. UCB S.A.
      • 6.2.1. Company Overview
      • 6.2.2. Product/Service Portfulio
      • 6.2.3. UCB S.A. Sales, Revenue, and Gross Margin
      • 6.2.4. UCB S.A. Revenue and Growth Rate
      • 6.2.5. UCB S.A. Market Share
      • 6.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.3. Valeant Pharmaceuticals North America LLC
      • 6.3.1. Company Overview
      • 6.3.2. Product/Service Portfulio
      • 6.3.3. Valeant Pharmaceuticals North America LLC Sales, Revenue, and Gross Margin
      • 6.3.4. Valeant Pharmaceuticals North America LLC Revenue and Growth Rate
      • 6.3.5. Valeant Pharmaceuticals North America LLC Market Share
      • 6.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.4. Alexza Pharmaceuticals
      • 6.4.1. Company Overview
      • 6.4.2. Product/Service Portfulio
      • 6.4.3. Alexza Pharmaceuticals Sales, Revenue, and Gross Margin
      • 6.4.4. Alexza Pharmaceuticals Revenue and Growth Rate
      • 6.4.5. Alexza Pharmaceuticals Market Share
      • 6.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.5. Veriton Pharma
      • 6.5.1. Company Overview
      • 6.5.2. Product/Service Portfulio
      • 6.5.3. Veriton Pharma Sales, Revenue, and Gross Margin
      • 6.5.4. Veriton Pharma Revenue and Growth Rate
      • 6.5.5. Veriton Pharma Market Share
      • 6.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 7 Acute Repetitive Seizures — Industry Analysis
    • 7.1. Introduction and Taxonomy
    • 7.2. Acute Repetitive Seizures Market – Key Trends
      • 7.2.1. Market Drivers
      • 7.2.2. Market Restraints
      • 7.2.3. Market Opportunities
    • 7.3. Key Mandates and Regulations
    • 7.4. Technulogy Roadmap and Timeline
    • 7.5. Acute Repetitive Seizures Market – Attractiveness Analysis
      • 7.5.1. By Product
      • 7.5.2. By Distribution Channel
      • 7.5.3. By Region
  • Chapter 8 Marketing Strategy Analysis
    • 8.1. Marketing Channel
    • 8.2. Direct Marketing
    • 8.3. Indirect Marketing
    • 8.4. Marketing Channel Development Trends
    • 8.5. Economic/Pulitical Environmental Change
  • Chapter 9 Report Conclusion & Key Insights
    • 9.1. Key Insights from Primary Interviews & Surveys Respondents
    • 9.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 10 Research Approach & Methodulogy
    • 10.1. Report Description
    • 10.2. Research Scope
    • 10.3. Research Methodulogy
      • 10.3.1. Secondary Research
      • 10.3.2. Primary Research
      • 10.3.3. Statistical Models
        • 10.3.3.1. Company Share Analysis Model
        • 10.3.3.2. Revenue Based Modeling
      • 10.3.4. Research Limitations

Inquiry For Buying

Acute Repetitive Seizures

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Acute Repetitive Seizures

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail PDF Sample Report

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com